Atypical hemolytic uremic syndrome with complement gene abnormality | UniteRare Disease Library

Overview

Also known as:

aHUS aHUS with complement gene abnormality atypical hemolytic uremic syndrome Atypical HUS Atypical HUS with complement gene abnormality

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event

Feb 2024Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

Mario Negri Institute for Pharmacological Research — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

CARBAMAZEPINE

CARBAMAZEPINE· Alembic Pharmaceuticals Inc.■ Boxed Warning

Carbamazepine is indicated for use as an anticonvulsant drug for partial seizures with complex symptomatology (psychomotor, temporal lobe)

View Details →FDA Label ↗

Clinical Trials

1 recruitingView all trials with filters →

N/A1 trial

Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases

N/A

Actively Recruiting

PI: Marina Noris, PhD (Istituto Di Ricerche Farmacologiche Mario Negri) · Sites: Ranica, BG

Specialists

View all specialists →

No specialists are currently listed for Atypical hemolytic uremic syndrome with complement gene abnormality.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Atypical hemolytic uremic syndrome with complement gene abnormality.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Atypical hemolytic uremic syndrome with complement gene abnormalityForum →

No community posts yet. Be the first to share your experience with Atypical hemolytic uremic syndrome with complement gene abnormality.

Start the conversation →

Latest news about Atypical hemolytic uremic syndrome with complement gene abnormality

No recent news articles for Atypical hemolytic uremic syndrome with complement gene abnormality.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Atypical hemolytic uremic syndrome with complement gene abnormality

Are there clinical trials for Atypical hemolytic uremic syndrome with complement gene abnormality?

Yes — 1 recruiting clinical trial is currently listed for Atypical hemolytic uremic syndrome with complement gene abnormality on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.